Investment Summary

Fosun Pharma Invests In Gland Pharma

On July 28, 2016, Fosun Pharma invested in life science company Gland Pharma from KKR

Investment Highlights
  • This is Fosun Pharma’s 2nd transaction in the Life Science sector.
  • This is Fosun Pharma’s 1st transaction in India.

Investment Summary
Date 2016-07-28
Target Gland Pharma
Sector Life Science
Investor(s) Fosun Pharma
Sellers(s) KKR
Deal Type Stake Purchase
Advisor(s) Jefferies (Financial)
Simpson Thacher & Bartlett
Cyril Amarchand Mangaldas (Legal)

Target

Gland Pharma

Hyderabad, India
Gland develops and manufactures generic injectables for use in nearly 90 countries on five continents, with a focus on the Indian and US markets. Since 1996, The Company has maintained a relationship with the Vetter family in Germany, and by 2003, Gland was the first company in India to get US Food and Drug Administration ("FDA") approval for pharmaceutical liquid injectable products. Gland's world-class manufacturing facilities have also received approvals from a number of key medical regulatory agencies around the globe including those in Australia, Germany and the UK, in addition to the World Health Organization.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Fosun Pharma

Shanghai, China
Category Company
Founded 1994
Sector Healthcare Services
Employees40,370
Revenue 41.4B CNY (2023)
DESCRIPTION

Fosun Pharma is a healthcare company in China that strategically covers important segments of the healthcare industry value chain, including pharmaceutical manufacturing, pharmaceutical distribution and retail, healthcare services, diagnostic products, and medical devices. Fosun Pharma was founded in 1994 and is based in Shanghai, China.

DEAL STATS #
Overall 2 of 4
Sector (Life Science) 2 of 2
Type (Stake Purchase) 1 of 1
Country (India) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-05-21 Ambrx

San Diego, California, United States

Ambrx is a clinical-stage biopharmaceutical company with a proprietary synthetic biology technology platform to design and develop next-generation antibody-drug conjugates (ADCs). The company is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety of its candidate therapeutics in multiple cancer indications, including ARX517, its proprietary ADC targeting PSMA for metastatic castration-resistant prostate cancer (mCRPC); ARX788, its proprietary ADC targeting human epidermal growth factor receptor 2 (HER2) for metastatic HER2+ breast cancer; and ARX305, its proprietary ADC targeting CD-70 for renal cell carcinoma. Ambrx was founded in 2003 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-17 Breas Medical AB

Mölnlycke, Sweden

Breas Medical AB is a manufacturer of home respiratory ventilators and sleep apnea products for the global home healthcare market sold in more than 40 countries.

Buy -

Seller(S) 1

SELLER

KKR

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1976
PE ASSETS 267.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.

DEAL STATS #
Overall 85 of 205
Sector (Life Science) 4 of 8
Type (Stake Purchase) 1 of 6
Country (India) 3 of 7
Year (2016) 8 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-05 Epicor Software

Austin, Texas, United States

Epicor Software is a global provider of industry-specific enterprise software to industrial-focused sectors. Epicor serves as a trusted partner for thousands of companies worldwide across key industries such as manufacturing, distribution, and retail. Epicor Software was founded in 1972 and is based in Austin, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-04 GO-JEK

Jakarta, Indonesia

GO-JEK is a mobile application-based platform in Indonesia that provides a range of services such as ride-hailing, food delivery, lifestyle services, and mobile payments. GO-JEK was founded in 2010 and is based in Jakarta, Indonesia.

Buy -
Mergr

Product

Company

Legal